{"id":2843,"date":"2017-10-22T22:17:45","date_gmt":"2017-10-22T14:17:45","guid":{"rendered":"http:\/\/www.farmasi.asia\/?p=2843"},"modified":"2017-10-22T22:17:45","modified_gmt":"2017-10-22T14:17:45","slug":"informasi-keamanan-eso-who-19102017","status":"publish","type":"post","link":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/","title":{"rendered":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor"},"content":{"rendered":"<p><!--Ads1--><\/p>\n<p><strong>Apoteker.Net<\/strong> &#8211; Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien.<\/p>\n<p>Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database, yakni:<\/p>\n<ol>\n<li>Ruxolitinib dan risiko neuropati perifer<\/li>\n<li>Desloratadine\/Loratadine dan risiko peningkatan berat badan pada anak<\/li>\n<li>Interaksi Ciprofloxacin dan Enalapril mengakibatkan peningkatan risiko gangguan ginjal akut<\/li>\n<li>Interaksi Rosuvastatin dan Ticagrelor mengakibatkan risiko Rhabdomyolysis<\/li>\n<p><!--Ads4-->\n<\/ol>\n<p>Informasi di atas agar dapat menjadi perhatian profesional kesehatan khususnya Dokter dan Apoteker.<\/p>\n<p>Terlampir surat resmi dari BPOM untuk disebarluaskan kepada anggota IDI dan IAI.<\/p>\n<figure id=\"attachment_2844\" aria-describedby=\"caption-attachment-2844\" style=\"width: 895px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Surat-Informasi-Keamanan-19-Oktober-2017.jpg?ssl=1\" target=\"_blank\" rel=\"noopener\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"size-full wp-image-2844\" src=\"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Surat-Informasi-Keamanan-19-Oktober-2017.jpg?resize=905%2C1280&#038;ssl=1\" alt=\"Surat Informasi Keamanan 19 Oktober 2017\" width=\"905\" height=\"1280\" \/><\/a><figcaption id=\"caption-attachment-2844\" class=\"wp-caption-text\">Klik <a href=\"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Surat-Informasi-Keamanan-19-Oktober-2017.jpg\" target=\"_blank\" rel=\"noopener\">di sini<\/a> untuk memperbesar gambar.<\/figcaption><\/figure>\n<p><!--Ads5--><\/p>\n<figure id=\"attachment_2845\" aria-describedby=\"caption-attachment-2845\" style=\"width: 895px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Penguatan-Signal-Interaksi-Obat-Ciprofloxacin-dan-Enalapril.jpg?ssl=1\" target=\"_blank\" rel=\"noopener\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"size-full wp-image-2845\" src=\"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Penguatan-Signal-Interaksi-Obat-Ciprofloxacin-dan-Enalapril.jpg?resize=905%2C1280&#038;ssl=1\" alt=\"Penguatan Signal Interaksi Obat Ciprofloxacin dan Enalapril\" width=\"905\" height=\"1280\" \/><\/a><figcaption id=\"caption-attachment-2845\" class=\"wp-caption-text\">Klik <a href=\"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Penguatan-Signal-Interaksi-Obat-Ciprofloxacin-dan-Enalapril.jpg\" target=\"_blank\" rel=\"noopener\">di sini<\/a> untuk memperbesar gambar.<\/figcaption><\/figure>\n<p><!--Ads2--><\/p>\n<figure id=\"attachment_2846\" aria-describedby=\"caption-attachment-2846\" style=\"width: 904px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Penguatan-Signal-Interaksi-Obat-Ciprofloxacin-dan-Enalapril-Lanjutan.jpg?ssl=1\" target=\"_blank\" rel=\"noopener\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"size-full wp-image-2846\" src=\"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Penguatan-Signal-Interaksi-Obat-Ciprofloxacin-dan-Enalapril-Lanjutan.jpg?resize=914%2C1280&#038;ssl=1\" alt=\"Penguatan Signal Interaksi Obat Ciprofloxacin dan Enalapril Lanjutan\" width=\"914\" height=\"1280\" \/><\/a><figcaption id=\"caption-attachment-2846\" class=\"wp-caption-text\">Klik <a href=\"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Penguatan-Signal-Interaksi-Obat-Ciprofloxacin-dan-Enalapril-Lanjutan.jpg\" target=\"_blank\" rel=\"noopener\">di sini<\/a> untuk memperbesar gambar.<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":12,"featured_media":2847,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[11],"tags":[251,335],"class_list":["post-2843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-obat-dan-penyakit","tag-bpom","tag-informasi-keamanan"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"editor\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Blog Apoteker.Net - Berita, Opini dan Informasi tentang Farmasi dan Apoteker\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net\" \/>\n\t\t<meta property=\"og:description\" content=\"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"905\" \/>\n\t\t<meta property=\"og:image:height\" content=\"362\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2017-10-22T14:17:45+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2017-10-22T14:17:45+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/jimmy.ahyari\/\" \/>\n\t\t<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/www.apoteker.net\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@apotekernet\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#blogposting\",\"name\":\"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\\\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net\",\"headline\":\"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\\\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor\",\"author\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/author\\\/editor\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/apoteker.net\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg?fit=905%2C362&ssl=1\",\"width\":905,\"height\":362},\"datePublished\":\"2017-10-22T22:17:45+08:00\",\"dateModified\":\"2017-10-22T22:17:45+08:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#webpage\"},\"articleSection\":\"Obat dan Penyakit, BPOM, Informasi Keamanan\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog#listItem\",\"position\":1,\"name\":\"Apoteker.Net\",\"item\":\"https:\\\/\\\/apoteker.net\\\/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/category\\\/obat-dan-penyakit\\\/#listItem\",\"name\":\"Obat dan Penyakit\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/category\\\/obat-dan-penyakit\\\/#listItem\",\"position\":2,\"name\":\"Obat dan Penyakit\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog#listItem\",\"name\":\"Apoteker.Net\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/#organization\",\"name\":\"Apoteker.Net\",\"description\":\"Berita, Opini dan Informasi tentang Farmasi dan Apoteker\",\"url\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/apoteker.net\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/LogoApotekerBlog250.png?fit=250%2C83&ssl=1\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#organizationLogo\",\"width\":250,\"height\":83,\"caption\":\"Blog Apoteker.Net Logo\"},\"image\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/jimmy.ahyari\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/author\\\/editor\\\/#author\",\"url\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/author\\\/editor\\\/\",\"name\":\"editor\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/07aa93ef08d8b7a658de58356a198ecbe731cc0218481ba565e3e1cd75db62bb?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"editor\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/www.apoteker.net\",\"https:\\\/\\\/twitter.com\\\/apotekernet\",\"https:\\\/\\\/www.instagram.com\\\/apotekernet\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/apoteker\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#webpage\",\"url\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/\",\"name\":\"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\\\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net\",\"description\":\"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/author\\\/editor\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/author\\\/editor\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/apoteker.net\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg?fit=905%2C362&ssl=1\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#mainImage\",\"width\":905,\"height\":362},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/informasi-keamanan-eso-who-19102017\\\/#mainImage\"},\"datePublished\":\"2017-10-22T22:17:45+08:00\",\"dateModified\":\"2017-10-22T22:17:45+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/\",\"name\":\"Apoteker Network Blog\",\"alternateName\":\"Apoteker.Net Blog\",\"description\":\"Berita, Opini dan Informasi tentang Farmasi dan Apoteker\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/apoteker.net\\\/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net","description":"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,","canonical_url":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#blogposting","name":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net","headline":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor","author":{"@id":"https:\/\/apoteker.net\/blog\/author\/editor\/#author"},"publisher":{"@id":"https:\/\/apoteker.net\/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg?fit=905%2C362&ssl=1","width":905,"height":362},"datePublished":"2017-10-22T22:17:45+08:00","dateModified":"2017-10-22T22:17:45+08:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#webpage"},"isPartOf":{"@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#webpage"},"articleSection":"Obat dan Penyakit, BPOM, Informasi Keamanan"},{"@type":"BreadcrumbList","@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/apoteker.net\/blog#listItem","position":1,"name":"Apoteker.Net","item":"https:\/\/apoteker.net\/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/apoteker.net\/blog\/category\/obat-dan-penyakit\/#listItem","name":"Obat dan Penyakit"}},{"@type":"ListItem","@id":"https:\/\/apoteker.net\/blog\/category\/obat-dan-penyakit\/#listItem","position":2,"name":"Obat dan Penyakit","previousItem":{"@type":"ListItem","@id":"https:\/\/apoteker.net\/blog#listItem","name":"Apoteker.Net"}}]},{"@type":"Organization","@id":"https:\/\/apoteker.net\/blog\/#organization","name":"Apoteker.Net","description":"Berita, Opini dan Informasi tentang Farmasi dan Apoteker","url":"https:\/\/apoteker.net\/blog\/","logo":{"@type":"ImageObject","url":"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2022\/05\/LogoApotekerBlog250.png?fit=250%2C83&ssl=1","@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#organizationLogo","width":250,"height":83,"caption":"Blog Apoteker.Net Logo"},"image":{"@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/jimmy.ahyari\/"]},{"@type":"Person","@id":"https:\/\/apoteker.net\/blog\/author\/editor\/#author","url":"https:\/\/apoteker.net\/blog\/author\/editor\/","name":"editor","image":{"@type":"ImageObject","@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/07aa93ef08d8b7a658de58356a198ecbe731cc0218481ba565e3e1cd75db62bb?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"editor"},"sameAs":["https:\/\/www.facebook.com\/www.apoteker.net","https:\/\/twitter.com\/apotekernet","https:\/\/www.instagram.com\/apotekernet\/","https:\/\/www.linkedin.com\/company\/apoteker"]},{"@type":"WebPage","@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#webpage","url":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/","name":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net","description":"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/apoteker.net\/blog\/#website"},"breadcrumb":{"@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#breadcrumblist"},"author":{"@id":"https:\/\/apoteker.net\/blog\/author\/editor\/#author"},"creator":{"@id":"https:\/\/apoteker.net\/blog\/author\/editor\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg?fit=905%2C362&ssl=1","@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#mainImage","width":905,"height":362},"primaryImageOfPage":{"@id":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/#mainImage"},"datePublished":"2017-10-22T22:17:45+08:00","dateModified":"2017-10-22T22:17:45+08:00"},{"@type":"WebSite","@id":"https:\/\/apoteker.net\/blog\/#website","url":"https:\/\/apoteker.net\/blog\/","name":"Apoteker Network Blog","alternateName":"Apoteker.Net Blog","description":"Berita, Opini dan Informasi tentang Farmasi dan Apoteker","inLanguage":"id-ID","publisher":{"@id":"https:\/\/apoteker.net\/blog\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Blog Apoteker.Net - Berita, Opini dan Informasi tentang Farmasi dan Apoteker","og:type":"article","og:title":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net","og:description":"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,","og:url":"https:\/\/apoteker.net\/blog\/informasi-keamanan-eso-who-19102017\/","og:image":"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg","og:image:secure_url":"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg","og:image:width":905,"og:image:height":362,"article:published_time":"2017-10-22T14:17:45+00:00","article:modified_time":"2017-10-22T14:17:45+00:00","article:publisher":"https:\/\/www.facebook.com\/jimmy.ahyari\/","article:author":"https:\/\/www.facebook.com\/www.apoteker.net","twitter:card":"summary","twitter:title":"Informasi Keamanan Hasil Analisis Laporan Efek Samping Obat (ESO) dari WHO untuk Ruxolitinib, Desloratadine\/Loratadine, Ciprofloxacin-Enalapril dan Rosuvastatin-Ticagrelor - Blog Apoteker.Net","twitter:description":"Apoteker.Net - Sehubungan dengan adanya informasi keamanan obat terbaru yang diperoleh dari WHO UMC-Signal, Badan Pengawas Obat dan Makanan (BPOM) Republik Indonesia menyampaikan informasi untuk tenaga kesehatan profesional sebagai upaya meningkatkan kehati-hatian dalam penggunaan obat di bawah ini untuk pasien. Informasi keamanan ini merupakan hasil analisis laporan Efek Samping Obat (ESO) dari WHO Global Database,","twitter:creator":"@apotekernet","twitter:image":"https:\/\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg"},"aioseo_meta_data":{"post_id":"2843","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":"","og_description":"","og_object_type":"article","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":"","og_article_tags":"","twitter_use_og":false,"twitter_card":"summary","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2022-05-12 17:42:51","updated":"2022-10-23 17:23:13","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/apoteker.net\/blog\" title=\"Apoteker.Net\">Apoteker.Net<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&rsaquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/apoteker.net\/blog\/category\/obat-dan-penyakit\/\" title=\"Obat dan Penyakit\">Obat dan Penyakit<\/a>\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Apoteker.Net","link":"https:\/\/apoteker.net\/blog"},{"label":"Obat dan Penyakit","link":"https:\/\/apoteker.net\/blog\/category\/obat-dan-penyakit\/"}],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/apoteker.net\/blog\/wp-content\/uploads\/2017\/10\/Header-Surat-Informasi-Keamanan-19-Oktober-2017.jpg?fit=905%2C362&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/posts\/2843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/comments?post=2843"}],"version-history":[{"count":0,"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/posts\/2843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/media\/2847"}],"wp:attachment":[{"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/media?parent=2843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/categories?post=2843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/apoteker.net\/blog\/wp-json\/wp\/v2\/tags?post=2843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}